LIfT Biosciences

LIfT Biosciences is a biotech company developing a first-in-class alpha neutrophil cell therapy to overcome treatment resistance in solid tumors. Their Immunomodulatory Alpha Neutrophils (IMANs) kill cancer cells directly and indirectly by recruiting the patient's immune system. The company is preparing initiatives with pharmaceutical partners to develop engineered CAR IMAN cell therapies.

Buy Funded Startups lists

Funding Round: Grant

Funding Amount: $300K

Date: 09-Oct-2024

Investors: ScaleReady

Markets: Biotechnology, Cell Therapy, Oncology

HQ: London, England, United Kingdom

Founded: 2016

Website: https://www.liftbiosciences.com/

LinkedIn: https://uk.linkedin.com/company/lift-biosciences

Twitter: https://twitter.com/liftbiosciences

Instagram: